Evidence-Based Complementary and Alternative Medicine

Research Article

The Efficacy of Moxibustion for Breast Cancer Patients with Chemotherapy-Induced Myelosuppression during Adjuvant Chemotherapy: A Randomized Controlled Study

Table 1

Comparison of the WBC counts at specific time points between the two groups.


Chemotherapy course	Group	n	WBC count
Chemotherapy course	Group	n	1^st week after chemotherapy (1–7 d)	2^nd week after chemotherapy (8–14 d)	3^rd week after chemotherapy (15–20d)

1^st course	MOX	48	5.03 ± 1.93 (36)	3.25 ± 1.76 (45)	6.67 ± 2.12 (47)
1^st course	CON	44	4.61 ± 1.68 (36)	3.11 ± 1.31 (39)	6.33 ± 2.35 (44)

2^nd course	MOX	48	5.08 ± 1.70 (38)	3.41 ± 1.42 (44)	5.86 ± 1.67 (46)
2^nd course	CON	44	5.33 ± 2.07 (33)	3.21 ± 1.12 (38)	5.47 ± 1.85 (44)

3^rd course	MOX	48	4.92 ± 1.68 (35)	3.50 ± 1.25 (44)	5.50 ± 1.85 (45)
3^rd course	CON	44	4.74 ± 1.98 (34)	3.22 ± 1.44 (40)	5.19 ± 1.15 (44)

4^th course	MOX	48	4.86 ± 1.94 (23)	3.51 ± 1.61 (33)	5.71 ± 1.63 (38)
4^th course	CON	44	5.04 ± 1.82 (25)	3.66 ± 2.17 (33)	5.22 ± 2.74 (36)

5^th course	MOX	33	5.22 ± 2.74 (19)	4.72 ± 1.63 (29)	5.79 ± 1.66 (33)
5^th course	CON	34	5.05 ± 2.11 (23)	5.20 ± 1.84 (25)	6.15 ± 1.79 (34)

6^th course	MOX	33	6.40 ± 2.00 (20)	4.33 ± 2.09 (21)	5.40 ± 1.75 (24)
6^th course	CON	34	4.33 ± 2.09 (14)	4.71 ± 1.27 (22)	5.42 ± 1.42 (14)

7^th course	MOX	20	5.38 ± 1.41 (12)	4.87 ± 1.82 (18)	5.08 ± 1.42 (20)
7^th course	CON	23	3.78 ± 1.46 (15)	4.67 ± 1.79 (20)	5.21 ± 1.01 (21)

8^th course	MOX	20	5.19 ± 2.43 (9)	5.35 ± 2.44 (8)	5.03 ± 1.66 (7)
8^th course	CON	23	3.95 ± 1.27 (6)	4.19 ± 1.04 (8)	5.86 ± 1.07 (7)

WBC counts are expressed as mean ± standard deviation x10⁹/L (number of cases). .